Preliminary experience in treating thoracic spinal tuberculosis via a posterior modified transfacet debridement, instrumentation, and interbody fusion

Table 1 Patient demographics, operative information, and disease characteristics

No.	Gender	Age (years)	Levels	Focal debridement	Operative time (min)	Blood loss (ml)	Follow-up (months)	Bone fusion (months)	Complications
1	F	39	T10–11	T10–11	210	500	42	6
2	F	62	T7–9	T7–8	230	300	45	9
3	M	52	T5–6.	T5–6	208	200	36	6
4	F	75	T5–7	T5–6	230	700	47	12
5	M	65	T6–7	T6–7	220	250	45	6
6	M	27	T11–L1	T11–12	160	200	36	6	Pain at the donor site
7	F	39	T11–12	T11–12	180	300	39	6
8	M	48	T1–2, T5–6	T5–6	230	300	35	6
9	M	64	T10–12	T10–11, T11–12	290	600	38	9
10	M	64	T8–9	T8–9	215	400	38	6
11	F	24	T4–L2	T6–7, T11–12	410	1800	29	12	Hypoproteinemia
12	F	81	T10–11	T10–11	240	500	40	6
13	F	59	T8–9	T8–9	152	100	45	6
14	F	39	T10–L2	T10–11	230	450	43	6
15	M	31	T11–L1	T11–12	200	400	36	6
16	M	64	T10–12	T10–11	195	600	39	6
17	F	76	T8–9	T8–9	202	500	37	6
18	M	24	T8–L2	T9–10, T11–12	310	800	40	9
19	M	55	T10–L2	T11–12	230	300	33	6
20	M	21	T4–12	T6–7, T9–10	360	1500	43	9	Water–electrolyte imbalance
21	M	33	T6–L1	T8–9, T11–12	320	1000	48	9
22	F	40	T10–L2	T11–12	220	450	33	6
23	F	23	T8–L3	T9–10, T12–L1	355	1300	41	12
24	M	30	T8–L1	T9–10	190	300	48	6
25	M	36	T11–L2	T11–12	210	700	42	6
26	M	23	T10–L4	T10–11	180	200	50	6
27	M	28	T11–L1	T11–12	110	200	31	6
28	M	42	T8–10	T8–9	270	500	40	6
29	M	39	T7–9	T8–9	160	300	36	6
30	M	31	T7–L1	T9–10, T10–11	240	600	37	6
31	M	26	T5–11	T6–7, T9–10	290	1200	46	9
32	M	44	T6–7	T6–7	190	200	40	6
33	F	60	T8–9	T8–9	180	300	42	9	Pain at the donor site
34	M	23	T5–6	T5–6	200	350	33	6
35	F	48	T9–10	T9–10	130	200	38	6
36	F	25	T7–8	T7–8	170	300	35	6
37	F	34	T6–8	T7–8	160	300	46	6

ISSN: 1749-799X